secwatch.observer — SEC 8-K summary
======================================

Issuer:     Marpai, Inc. (MRAI)
CIK:        0001844392
Form:       8-K
Filed at:   2023-03-29T23:59:59+00:00
Accession:  0000950170-23-010619
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Marpai reports FY 2022 revenue up 71% to $24.3M but net loss widens to $26.5M
-----------------------------------------------------------------------------

- Q4 2022 net revenue $7.6M, up 54% sequentially from Q3 2022; FY net revenue $24.3M.
- FY 2022 net loss $26.5M vs $16.0M in 2021; operating loss $27.0M vs $15.9M.
- Adjusted EBITDA for FY 2022 was negative $20.0M, compared to negative $12.7M in 2021.
- Employees covered under health plans surged to 42,107 at Dec 31, 2022 (16,357 at Sep 30, 2022), driven by Maestro Health acquisition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1844392/000095017023010619/0000950170-23-010619-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1844392/000095017023010619/mrai-20230329.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-010619

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer